To assess the role of MDP/NOD2 signaling in modulating iColAM and niColAM populations, we analyzed publicly available transcriptomic datasets of DSS-induced colitis spanning the acute, chronic, and recovery phases (Figure 6A), using composite gene signatures of i iColAM and niColAM subsets. The gene discussed is NOD2; the disease is colitis.